Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1726 AL 1740

The value of electrochemical skin conductance measurement by Sudoscan® for assessing autonomic dysfunction in peripheral neuropathies beyond diabetes

Lefaucheur JP.

Neurophysiol Clin. 2023 Apr;53(2):102859. doi: 10.1016/j.neucli.2023.102859. Epub 2023 Mar 24.

Baseline characteristics of the North American prodromal Synucleinopathy cohort

Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS; North American Prodromal Synucleinopathy (NAPS) Consortium.

Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8.

Punding in Parkinson's Disease: An Update

Rajalingam R, Fasano A.

Mov Disord Clin Pract. 2023 Apr 23;10(7):1035-1047. doi: 10.1002/mdc3.13748. eCollection 2023 Jul.

Exploring the Potential of Antidiabetic Agents as Therapeutic Approaches for Alzheimer's and Parkinson's Diseases: A Comprehensive Review

Koshatwar M, Acharya S, Prasad R, Lohakare T, Wanjari M, Taksande AB.

Cureus. 2023 Sep 6;15(9):e44763. doi: 10.7759/cureus.44763. eCollection 2023 Sep.

The Application of Deep Brain Stimulation for Parkinson's Disease on the Motor Pathway: A Bibliometric Analysis across 10 Years

Song YT, Liu YB, Xiang HB, Manyande A, He ZG.

Curr Med Sci. 2023 Dec;43(6):1247-1257. doi: 10.1007/s11596-023-2811-9. Epub 2023 Dec 28.

Defining the Riddle in Order to Solve It: There Is More Than One "Parkinson's Disease"

Outeiro TF, Alcalay RN, Antonini A, Attems J, Bonifati V, Cardoso F, Chesselet MF, Hardy J, Madeo G, McKeith I, Mollenhauer B, Moore DJ, Rascol O, Schlossmacher MG, Soreq H, Stefanis L, Ferreira JJ.

Mov Disord. 2023 Jul;38(7):1127-1142. doi: 10.1002/mds.29419. Epub 2023 May 8.

Rotenone-Induced Model of Parkinson's Disease: Beyond Mitochondrial Complex I Inhibition

Ibarra-Gutiérrez MT, Serrano-García N, Orozco-Ibarra M.

Mol Neurobiol. 2023 Apr;60(4):1929-1948. doi: 10.1007/s12035-022-03193-8. Epub 2023 Jan 3.

A Narrative Review of Current Status and Future Perspective of Telemedicine for Parkinson's Disease, Dementia, and Intractable Neurological Diseases in Japan

Oyama G, Ogawa M, Sekimoto S, Hatano T, Hattori N.

Juntendo Iji Zasshi. 2023 Jan 26;69(1):14-20. doi: 10.14789/jmj.JMJ22-0031-R. eCollection 2023.

Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson's Disease

Chen K, Wang H, Ilyas I, Mahmood A, Hou L.

Brain Sci. 2023 Apr 7;13(4):634. doi: 10.3390/brainsci13040634.

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson's Disease

Guedes BFS, Cardoso SM, Esteves AR.

Biomedicines. 2023 May 3;11(5):1349. doi: 10.3390/biomedicines11051349.

The Park Sleep subtype in Parkinson's disease: from concept to clinic

Tall P, Qamar MA, Rosenzweig I, Raeder V, Sauerbier A, Heidemarie Z, Falup-Pecurariu C, Chaudhuri KR.

Expert Opin Pharmacother. 2023 Sep-Dec;24(15):1725-1736. doi: 10.1080/14656566.2023.2242786. Epub 2023 Aug 10.

Visual Dysfunction in Parkinson's Disease

Nieto-Escamez F, Obrero-Gaitán E, Cortés-Pérez I.

Brain Sci. 2023 Aug 7;13(8):1173. doi: 10.3390/brainsci13081173.

Progress in circRNA-Targeted Therapy in Experimental Parkinson's Disease

Titze-de-Almeida SS, Titze-de-Almeida R.

Pharmaceutics. 2023 Jul 28;15(8):2035. doi: 10.3390/pharmaceutics15082035.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias